How to Buy Royalty Pharma Stock
Royalty Pharma PLC
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States.
Royalty Pharma stock last closed at $27.27, down 2.19% from the previous day, and has decreased 17.24% in one year. It has overperformed other stocks in the Biotechnology industry by 0.02 percentage points. Royalty Pharma stock is currently +5.21% from its 52-week low of $25.92, and -21.3% from its 52-week high of $34.65.
As of May 17, 2024, there are 597.44M RPRX shares outstanding. The market capitalization of RPRX is $16.29B. In the past 24 hours, 1.89M RPRX shares were traded.
How to Buy Royalty Pharma Stock
Not sure how to invest in Royalty Pharma stock? Here's how.
- Decide where to buy Royalty Pharma stock: You need to choose an online brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you determine where to buy Royalty Pharma stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit money your investment account: Choose your payment method and add your details.
- Analyze Royalty Pharma stock: The Royalty Pharma ticker symbol is RPRX. Is Royalty Pharma stock a good investment? Should you buy shares of RPRX? How do RPRX's underlying business fundamentals look? Do top analysts think Royalty Pharma is a good buy? Why has RPRX's stock price moved recently? (Hint: Our stock research tools can help you understand if RPRX is a good stock to buy).
- Execute your RPRX purchase: Decide if you will purchase RPRX shares at the current market price or use a limit order to purchase RPRX stock at a given price.
- Keep tabs on your RPRX position: Create a watchlist to get the latest news on your new investment in Royalty Pharma stock.
Step 1: Decide where to buy Royalty Pharma stock
You will need a brokerage account in order to access the NASDAQ market and buy RPRX shares.
Our recommended brokerage: eToro
In our opinion, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world financial markets: From Tech to Energy, New York to Tokyo — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by opening an account with eToro today.
Open eToro AccountStep 2: Create your brokerage account
Now that you've selected the right brokerage, you need to fill out some personal information so you are able to buy RPRX today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to start your new brokerage account.
- Send your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you've created your account on the highest rated app to buy and sell stocks, you can securely and quickly fund your account:
Check out the walkthrough below for more details depositing funds into your new investment account.
Step 4: Analyze Royalty Pharma stock
After you have identified the best place to buy Royalty Pharma stock, it's critical to research their stock before you buy, so you truly understand the risk as well as the upside.
Overview of key RPRX info
Royalty Pharma Overview
WallStreetZen was designed to help everyday investors do better fundamental analysis in less time.
You can view all of the due diligence checks on RPRX's stock page.
How is RPRX stock valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge RPRX's fair value.
Using relative valuations metrics:
- RPRX could be overvalued based on its P/E ratio of 15.23x, relative to Biotechnology industry P/E ratio of 8.47x
- RPRX could be undervalued based on its P/B ratio of 1.65x, relative to Biotechnology industry P/B ratio of 6.01x
- RPRX could be undervalued based on its PEG ratio of 0.28x
You can access additional valuation analysis on RPRX's stock here.
RPRX Financial Summary
Passed Financial Due Diligence Checks:
- There are more short-term assets than short-term liabilities on the RPRX balance sheet.
- RPRX's operating cash flow of $2.62B allows it to safely service it's debt of $6.14B.
- RPRX profit margin has gone up from 14.1% to 35.7% in the past year.
- RPRX earnings of $983.33M is not sufficient to cover its interest payments.
Failed Financial Due Diligence Checks:
- RPRX has a relatively high debt to equity ratio of 0.64.
- There are more long-term liabilities than short-term assets on the RPRX balance sheet.
Do analysts think it's a good time to buy Royalty Pharma stock
Out of 3 sell side analysts who monitor RPRX, the consensus analyst rating on RPRX is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are forecasting on the Royalty Pharma stock forecast page.
Metrics for Advanced RPRX Traders
Is RPRX Growing Revenue?
Last year, RPRX earnings were $798.86M. In the past 3 year, RPRX's earnings have gone up by 57.82% per year. This was faster than the Biotechnology industry average of 9.87%.
Last year, RPRX revenue was $2.24B. In the last 4 year, RPRX's revenue has gone up by 4.46% per year. This was slower than the Biotechnology industry average of 32.19%.
Find out more about RPRX's earnings and revenue performance here.
Who is buying/selling RPRX?
Over the last year, executives and large shareholders at RPRX have sold more shares than they have bought.
Bonnie L. Bassler, Director of RPRX, was the latest RPRX insider to buy. They bought $37,482.72 worth of RPRX shares on Mar 28, 2024.
Dig into more about who owns RPRX stock here.
Can I rely on RPRX as an income stream?
No, Royalty Pharma doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Execute your RPRX purchase
There are two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly fine. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a particular price, place a limit order.
Press the Open Trade button and eToro will place your order.
If you need additional help with investing in stocks on eToro, watch the helpful video below:
Step 6: Keep tabs on your RPRX position
Now that you own some RPRX stock, you'll want to keep up with your new investment.
Create a watchlist to track the latest developments regarding your RPRX stock.
RPRX Feed
How to Buy Stock in Royalty Pharma
To summarize, here are the 6 steps to buy stock in Royalty Pharma:
- Decide where to buy Royalty Pharma stock
- Create your brokerage account
- Deposit money your investment account
- Analyze Royalty Pharma stock
- Execute your RPRX purchase
- Keep tabs on your RPRX position
If you are looking for a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to keep track of your new investment in Royalty Pharma, add RPRX to your watchlist by clicking the button below.
Related Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.